Ascelia Pharma publishes Orviglance liver MRI contrast agent study in JMRI
Ascelia Pharma announced publication of a peer-reviewed Orviglance clinical study in the Journal of Magnetic Resonance Imaging. Results were already presented via the journal article, not flagged for a future medical meeting. Study assessed a single oral dose in adults with hepatic impairment versus those without impai